foxm1激活的IGF2BP3通过稳定RRM2 mRNA以m6a依赖的方式抑制铁凋亡,从而促进肝癌细胞恶性表型和M2巨噬细胞极化。

IF 3.5 2区 生物学 Q3 CELL BIOLOGY
Heng Gao, Lei Shi, Jinfeng Liu, Yingren Zhao, Fenjing Du, Yingli He, Xin Yang, Ning Song, Juan Wen, Gezhi Zheng
{"title":"foxm1激活的IGF2BP3通过稳定RRM2 mRNA以m6a依赖的方式抑制铁凋亡,从而促进肝癌细胞恶性表型和M2巨噬细胞极化。","authors":"Heng Gao, Lei Shi, Jinfeng Liu, Yingren Zhao, Fenjing Du, Yingli He, Xin Yang, Ning Song, Juan Wen, Gezhi Zheng","doi":"10.1007/s11010-024-05170-2","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Ferroptosis has a crucial role in human carcinogenesis. N6-methyladenosine (m6A) reader insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3) suppresses ferroptosis of hepatocellular carcinoma (HCC) cells. Here, we examined the effects and molecular determinants of IGF2BP3-mediated ferroptosis on malignant behaviors of HCC cells.</p><p><strong>Methods: </strong>Ferroptosis was evaluated by measuring the levels of malondialdehyde (MDA), glutathione (GSH), reactive oxygen species (ROS), and lipid ROS. HCC cell malignant phenotypes were evaluated by colony formation assay, wound healing assay, and transwell invasion assay. The CD206<sup>+</sup> M2-like macrophages were assessed by flow cytometry. m6A RNA immunoprecipitation (MeRIP) was applied to assess the m6A modification of ribonucleotide reductase regulatory subunit M2 (RRM2). RNA immunoprecipitation (RIP) assay was performed to evaluate the interaction of IGF2BP3 and RRM2. Chromatin immunoprecipitation (ChIP) and dual-luciferase reporter assays were conducted to confirm the interaction between forkhead box M1 (FOXM1) and IGF2BP3.</p><p><strong>Results: </strong>Human HCC tumors showed increased expression of IGF2BP3 compared with adjacent normal tissues. Disruption of IGF2BP3 promoted cell ferroptosis. Moreover, disruption of IGF2BP3 hindered HCC cell growth, invasiveness, and motility and impeded THP1-derived macrophage M2 polarization and migration by inducing ferroptosis. Additionally, IGF2BP3 disruption repressed xenograft growth in vivo. Mechanistically, IGF2BP3 enhanced RRM2 mRNA stability and elevated its protein expression by reading its m6A modification. Overexpression of RRM2 reversed sh-IGF2BP3-mediated ferroptosis and weakened sh-IGF2BP3-mediated suppression of HCC cell malignant phenotypes and macrophage M2 polarization. Furthermore, IGF2BP3 was a downstream target of FOXM1, and knockdown of FOXM1 induced ferroptosis and inhibited cell malignant phenotypes by downregulating IGF2BP3.</p><p><strong>Conclusion: </strong>FOXM1-induced IGF2BP3 upregulation promotes HCC cell malignant behaviors and macrophages M2 polarization by repressing ferroptosis via m6A-dependent regulation of RRM2 mRNA. Targeting FOXM1/IGF2BP3/RRM2 to enhance ferroptosis might be exploited as a potent therapeutic strategy for HCC.</p>","PeriodicalId":18724,"journal":{"name":"Molecular and Cellular Biochemistry","volume":" ","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2024-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"FOXM1-activated IGF2BP3 promotes cell malignant phenotypes and M2 macrophage polarization in hepatocellular carcinoma by inhibiting ferroptosis via stabilizing RRM2 mRNA in an m6A-dependent manner.\",\"authors\":\"Heng Gao, Lei Shi, Jinfeng Liu, Yingren Zhao, Fenjing Du, Yingli He, Xin Yang, Ning Song, Juan Wen, Gezhi Zheng\",\"doi\":\"10.1007/s11010-024-05170-2\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Ferroptosis has a crucial role in human carcinogenesis. N6-methyladenosine (m6A) reader insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3) suppresses ferroptosis of hepatocellular carcinoma (HCC) cells. Here, we examined the effects and molecular determinants of IGF2BP3-mediated ferroptosis on malignant behaviors of HCC cells.</p><p><strong>Methods: </strong>Ferroptosis was evaluated by measuring the levels of malondialdehyde (MDA), glutathione (GSH), reactive oxygen species (ROS), and lipid ROS. HCC cell malignant phenotypes were evaluated by colony formation assay, wound healing assay, and transwell invasion assay. The CD206<sup>+</sup> M2-like macrophages were assessed by flow cytometry. m6A RNA immunoprecipitation (MeRIP) was applied to assess the m6A modification of ribonucleotide reductase regulatory subunit M2 (RRM2). RNA immunoprecipitation (RIP) assay was performed to evaluate the interaction of IGF2BP3 and RRM2. Chromatin immunoprecipitation (ChIP) and dual-luciferase reporter assays were conducted to confirm the interaction between forkhead box M1 (FOXM1) and IGF2BP3.</p><p><strong>Results: </strong>Human HCC tumors showed increased expression of IGF2BP3 compared with adjacent normal tissues. Disruption of IGF2BP3 promoted cell ferroptosis. Moreover, disruption of IGF2BP3 hindered HCC cell growth, invasiveness, and motility and impeded THP1-derived macrophage M2 polarization and migration by inducing ferroptosis. Additionally, IGF2BP3 disruption repressed xenograft growth in vivo. Mechanistically, IGF2BP3 enhanced RRM2 mRNA stability and elevated its protein expression by reading its m6A modification. Overexpression of RRM2 reversed sh-IGF2BP3-mediated ferroptosis and weakened sh-IGF2BP3-mediated suppression of HCC cell malignant phenotypes and macrophage M2 polarization. Furthermore, IGF2BP3 was a downstream target of FOXM1, and knockdown of FOXM1 induced ferroptosis and inhibited cell malignant phenotypes by downregulating IGF2BP3.</p><p><strong>Conclusion: </strong>FOXM1-induced IGF2BP3 upregulation promotes HCC cell malignant behaviors and macrophages M2 polarization by repressing ferroptosis via m6A-dependent regulation of RRM2 mRNA. Targeting FOXM1/IGF2BP3/RRM2 to enhance ferroptosis might be exploited as a potent therapeutic strategy for HCC.</p>\",\"PeriodicalId\":18724,\"journal\":{\"name\":\"Molecular and Cellular Biochemistry\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2024-12-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Molecular and Cellular Biochemistry\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.1007/s11010-024-05170-2\",\"RegionNum\":2,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"CELL BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular and Cellular Biochemistry","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1007/s11010-024-05170-2","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:上铁在人类癌变中起重要作用。n6 -甲基腺苷(m6A)阅读器胰岛素样生长因子2 mrna结合蛋白3 (IGF2BP3)抑制肝细胞癌(HCC)细胞铁凋亡。在这里,我们研究了igf2bp3介导的铁凋亡对HCC细胞恶性行为的影响和分子决定因素。方法:通过测定丙二醛(MDA)、谷胱甘肽(GSH)、活性氧(ROS)和脂质ROS水平来评估铁下垂。通过菌落形成实验、伤口愈合实验和transwell侵袭实验评估HCC细胞的恶性表型。流式细胞术检测CD206+ m2样巨噬细胞。采用m6A RNA免疫沉淀法(MeRIP)评价m6A修饰核糖核苷酸还原酶调控亚基M2 (RRM2)的效果。采用RNA免疫沉淀法(RIP)评价IGF2BP3与RRM2的相互作用。通过染色质免疫沉淀(ChIP)和双荧光素酶报告基因检测来证实叉头盒M1 (FOXM1)和IGF2BP3之间的相互作用。结果:人肝癌肿瘤IGF2BP3的表达明显高于癌旁正常组织。破坏IGF2BP3促进细胞铁下垂。此外,IGF2BP3的破坏阻碍了HCC细胞的生长、侵袭性和运动,并通过诱导铁凋亡阻碍thp1来源的巨噬细胞M2极化和迁移。此外,IGF2BP3的破坏抑制了异种移植物在体内的生长。机制上,IGF2BP3通过读取其m6A修饰,增强了RRM2 mRNA的稳定性,提高了RRM2蛋白的表达。RRM2过表达逆转了sh- igf2bp3介导的铁凋亡,减弱了sh- igf2bp3介导的肝癌细胞恶性表型和巨噬细胞M2极化的抑制。此外,IGF2BP3是FOXM1的下游靶点,敲低FOXM1可诱导铁下垂并通过下调IGF2BP3抑制细胞恶性表型。结论:foxm1诱导的IGF2BP3上调通过m6a依赖性调节RRM2 mRNA抑制铁凋亡,从而促进HCC细胞恶性行为和巨噬细胞M2极化。以FOXM1/IGF2BP3/RRM2为靶点,增强铁下沉可能是HCC的一种有效治疗策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
FOXM1-activated IGF2BP3 promotes cell malignant phenotypes and M2 macrophage polarization in hepatocellular carcinoma by inhibiting ferroptosis via stabilizing RRM2 mRNA in an m6A-dependent manner.

Background: Ferroptosis has a crucial role in human carcinogenesis. N6-methyladenosine (m6A) reader insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3) suppresses ferroptosis of hepatocellular carcinoma (HCC) cells. Here, we examined the effects and molecular determinants of IGF2BP3-mediated ferroptosis on malignant behaviors of HCC cells.

Methods: Ferroptosis was evaluated by measuring the levels of malondialdehyde (MDA), glutathione (GSH), reactive oxygen species (ROS), and lipid ROS. HCC cell malignant phenotypes were evaluated by colony formation assay, wound healing assay, and transwell invasion assay. The CD206+ M2-like macrophages were assessed by flow cytometry. m6A RNA immunoprecipitation (MeRIP) was applied to assess the m6A modification of ribonucleotide reductase regulatory subunit M2 (RRM2). RNA immunoprecipitation (RIP) assay was performed to evaluate the interaction of IGF2BP3 and RRM2. Chromatin immunoprecipitation (ChIP) and dual-luciferase reporter assays were conducted to confirm the interaction between forkhead box M1 (FOXM1) and IGF2BP3.

Results: Human HCC tumors showed increased expression of IGF2BP3 compared with adjacent normal tissues. Disruption of IGF2BP3 promoted cell ferroptosis. Moreover, disruption of IGF2BP3 hindered HCC cell growth, invasiveness, and motility and impeded THP1-derived macrophage M2 polarization and migration by inducing ferroptosis. Additionally, IGF2BP3 disruption repressed xenograft growth in vivo. Mechanistically, IGF2BP3 enhanced RRM2 mRNA stability and elevated its protein expression by reading its m6A modification. Overexpression of RRM2 reversed sh-IGF2BP3-mediated ferroptosis and weakened sh-IGF2BP3-mediated suppression of HCC cell malignant phenotypes and macrophage M2 polarization. Furthermore, IGF2BP3 was a downstream target of FOXM1, and knockdown of FOXM1 induced ferroptosis and inhibited cell malignant phenotypes by downregulating IGF2BP3.

Conclusion: FOXM1-induced IGF2BP3 upregulation promotes HCC cell malignant behaviors and macrophages M2 polarization by repressing ferroptosis via m6A-dependent regulation of RRM2 mRNA. Targeting FOXM1/IGF2BP3/RRM2 to enhance ferroptosis might be exploited as a potent therapeutic strategy for HCC.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Molecular and Cellular Biochemistry
Molecular and Cellular Biochemistry 生物-细胞生物学
CiteScore
8.30
自引率
2.30%
发文量
293
审稿时长
1.7 months
期刊介绍: Molecular and Cellular Biochemistry: An International Journal for Chemical Biology in Health and Disease publishes original research papers and short communications in all areas of the biochemical sciences, emphasizing novel findings relevant to the biochemical basis of cellular function and disease processes, as well as the mechanics of action of hormones and chemical agents. Coverage includes membrane transport, receptor mechanism, immune response, secretory processes, and cytoskeletal function, as well as biochemical structure-function relationships in the cell. In addition to the reports of original research, the journal publishes state of the art reviews. Specific subjects covered by Molecular and Cellular Biochemistry include cellular metabolism, cellular pathophysiology, enzymology, ion transport, lipid biochemistry, membrane biochemistry, molecular biology, nuclear structure and function, and protein chemistry.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信